ميسيلات إيناسيدينيب (1650550-25-6)
Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia. Product Name: Enasidenib mesylate CAS No.: 1650550-25-6 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C20H21F6N7O4S Molecular Weight: 569.48 Shelf Life: 2 Years Package: 25kg/drum
